Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-7 of 7
Keywords: tamoxifen
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Andrea Muñoz-Ayala, Brenda Chimal-Vega, Nicolás Serafín-Higuera, Octavio Galindo-Hernández, Gladys Ramírez-Rosales, Iván Córdova-Guerrero, Luis Fernando Gómez-Lucas, Victor García-González
Journal:
Bioscience Reports
Biosci Rep (2024) 44 (8): BSR20240444.
Published: 05 August 2024
...Andrea Muñoz-Ayala; Brenda Chimal-Vega; Nicolás Serafín-Higuera; Octavio Galindo-Hernández; Gladys Ramírez-Rosales; Iván Córdova-Guerrero; Luis Fernando Gómez-Lucas; Victor García-González Objective: Estrogen receptor-positive (ER+) breast cancer represents about 80% of cases, tamoxifen...
Includes: Supplementary data
Articles
Journal:
Bioscience Reports
Biosci Rep (2021) 41 (9): BSR20203020.
Published: 03 September 2021
...Yanyan Wang; Xiaonan Gong; Yujie Zhang Tamoxifen is an estrogen receptor (ER) antagonist that is most commonly used for the treatment of ER-positive breast cancer. However, tamoxifen resistance remains a major cause of cancer recurrence and progression. Here, we aimed to identify hub genes...
Includes: Supplementary data
Articles
Journal:
Bioscience Reports
Biosci Rep (2018) 38 (6): BSR20180595.
Published: 07 December 2018
... and vitamin D receptor (VDR) expression on the tamoxifen resistance of CSCs. Methods: MCF-7 cells were treated with 1,25(OH) 2 D 3 and their levels of VDR expression, viability, and apoptosis were detected. CD133 + MCF-7 stem cells were identified and transfected with a VDR-overexpression plasmid...
Articles
Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation
Open AccessPengpeng Yan, Huanna Tang, Xiaoying Chen, Shuiyu Ji, Wei Jin, Jiaming Zhang, Jia Shen, Hao Deng, Xiang Zhao, Quanquan Shen, Hongfeng Huang
Journal:
Bioscience Reports
Biosci Rep (2018) 38 (6): BSR20180240.
Published: 21 November 2018
...Pengpeng Yan; Huanna Tang; Xiaoying Chen; Shuiyu Ji; Wei Jin; Jiaming Zhang; Jia Shen; Hao Deng; Xiang Zhao; Quanquan Shen; Hongfeng Huang Peritoneal fibrosis is a severe complication arising from long-term peritoneal dialysis (PD). Tamoxifen (Tamo) has been clinically proven effective in a series...
Articles
(–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells
Available to Purchase
Journal:
Bioscience Reports
Biosci Rep (2011) 31 (2): 99–108.
Published: 29 October 2010
...Fulvia Farabegoli; Alessio Papi; Marina Orlandi The activation of the EGFR (epidermal growth factor receptor) signalling pathway is one of the key mechanisms underlying the development of resistance to tamoxifen in breast cancer patients. As EGCG [(–)-epigallocatechin-3-gallate], the most active...
Includes: Supplementary data
Articles
Concentration Dependent Different Action of Tamoxifen on Membrane Fluidity
Available to Purchase
Journal:
Bioscience Reports
Biosci Rep (2007) 27 (4-5): 247–255.
Published: 06 August 2007
...Nadide Kazanci; Feride Severcan Tamoxifen (TAM) is a non-steroidal antiestrogen drug, which is widely used to prevent and treat breast, liver, pancreas and brain cancers. The present work investigates, in detail, the concentration dependent behavior of TAM (varying from 1 mol% to 45 mol...
Articles
Tamoxifen Increases Membrane Fluidity at High Concentrations
Available to Purchase
Journal:
Bioscience Reports
Biosci Rep (2000) 20 (3): 177–184.
Published: 01 June 2000
... of the factors in this discrepancy. Turbidity(absorbance at 440 nm) and Fourier transform infrared spectroscopicstudies reveal that tamoxifen causes opposite effects on membranefluidity at low (1 mol.%) and high (30 mol.%) tamoxifen concentrations. Lowtamoxifen concentrations increase the absorbance in the gel...